Free Trial

Koninklijke Philips (NYSE:PHG) Raised to "Buy" at Wall Street Zen

Koninklijke Philips logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Koninklijke Philips (PHG) from a "hold" to a Buy in a research note issued on Saturday.
  • Despite that upgrade, several other firms (Weiss Ratings, Zacks) have recently downgraded Philips and MarketBeat shows a consensus rating of Hold, reflecting mixed analyst sentiment.
  • Philips recently beat quarterly expectations with $0.70 EPS vs. $0.50 expected and $5.98B revenue vs. $5.03B expected; the stock trades near $26 with a $25.2B market cap and a 52‑week range of $21.95–$33.44.
  • Five stocks we like better than Koninklijke Philips.

Koninklijke Philips (NYSE:PHG - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday.

A number of other analysts have also recently weighed in on the company. Weiss Ratings cut Koninklijke Philips from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Thursday, April 2nd. Zacks Research downgraded Koninklijke Philips from a "strong-buy" rating to a "hold" rating in a report on Monday, April 13th. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold".

Read Our Latest Research Report on PHG

Koninklijke Philips Trading Down 0.6%

Shares of NYSE:PHG opened at $26.18 on Friday. Koninklijke Philips has a 52 week low of $21.95 and a 52 week high of $33.44. The company's 50 day moving average is $28.45 and its two-hundred day moving average is $28.43. The company has a market cap of $25.20 billion, a PE ratio of 24.69, a P/E/G ratio of 6.84 and a beta of 0.74. The company has a current ratio of 1.32, a quick ratio of 0.94 and a debt-to-equity ratio of 0.63.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its quarterly earnings data on Tuesday, February 10th. The technology company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.20. The business had revenue of $5.98 billion during the quarter, compared to analysts' expectations of $5.03 billion. Koninklijke Philips had a net margin of 5.09% and a return on equity of 13.68%. Equities analysts predict that Koninklijke Philips will post 1.86 earnings per share for the current fiscal year.

Institutional Trading of Koninklijke Philips

Hedge funds and other institutional investors have recently made changes to their positions in the company. Johnson Financial Group Inc. acquired a new stake in shares of Koninklijke Philips during the third quarter worth about $27,000. Whipplewood Advisors LLC increased its position in shares of Koninklijke Philips by 923.7% during the first quarter. Whipplewood Advisors LLC now owns 993 shares of the technology company's stock worth $27,000 after purchasing an additional 896 shares in the last quarter. Flagship Harbor Advisors LLC acquired a new stake in shares of Koninklijke Philips during the fourth quarter worth about $31,000. CIBC Private Wealth Group LLC increased its position in shares of Koninklijke Philips by 179.6% during the fourth quarter. CIBC Private Wealth Group LLC now owns 1,272 shares of the technology company's stock worth $34,000 after purchasing an additional 817 shares in the last quarter. Finally, Navalign LLC acquired a new stake in shares of Koninklijke Philips during the fourth quarter worth about $54,000. Institutional investors and hedge funds own 13.67% of the company's stock.

Koninklijke Philips Company Profile

(Get Free Report)

Koninklijke Philips N.V. NYSE: PHG, commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips' principal activities center on medical technologies and personal health.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Koninklijke Philips Right Now?

Before you consider Koninklijke Philips, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.

While Koninklijke Philips currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines